Review
Accepted on 31 Jan 2026
sAlpha-7 Nicotinic Acetylcholine Receptor: Targeting the interplay between inflammation, Renin-Angiotensin Aldosterone System, and nervous system for the novel treatment of heart failure
in Cardiovascular and Smooth Muscle Pharmacology